Bio-Techne Corp (TECH)
Nasdaq: TECH · Biological Products, (No Diagnostic Substances) · Minneapolis, MN · filing with the SEC since 1995
Grade6.3
◀ Past 7.2● Present 7.3▶ Future 4.2
Filings
214 filings since 2017 beside 380 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-Q
Quarterly report for the quarter ending Dec 31, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by Feb 9, 2027
10-K
Annual report for the fiscal year ending Jun 30, 2027Large accelerated filers have 60 days after the fiscal year ends.
by Aug 29, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Sep 19, 2025.
Filings a yearinsider forms included
5662644962555777
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Jun 26, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 23, 2026
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Jun 26, 2026
8-K items 1.01, 5.02, 9.01
Major agreement signed; Officer or director change · Current report
Jun 23, 2026
Feb 11, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Feb 9, 2026
Nov 5, 2025
8-K items 2.02, 5.07, 8.01, 9.01
Results released; Shareholder vote; Other event · Current report
Oct 30, 2025
40 of 214 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.